Literature DB >> 24486350

Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs.

Amita Gupta1, Jyoti S Mathad2, Wei-Teng Yang3, Harjot K Singh2, Nikhil Gupte4, Vidya Mave4, Renu Bharadwaj5, K Zaman6, Eliza Roy6, Robert C Bollinger7, Ramesh Bhosale5, Mark C Steinhoff8.   

Abstract

BACKGROUND: Our understanding of the mother-to-child transfer of serotype-specific pneumococcal antibodies is limited in non-immunized, HIV-positive women.
METHODS: We compared geometric mean antibody concentrations (GMCs), geometric mean transplacental cord:maternal ratios (GMRs) and proportions of samples with protective antibody concentration (≥0.35μg/ml) to serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F between 74 HIV-infected and 98 HIV-uninfected mother-infant pairs who had not received pneumococcal immunization in South Asia. Multivariable analysis was performed to assess the influence of HIV on protective antibody concentrations.
RESULTS: HIV-infected mothers and their infants exhibited lower GMCs and GMRs than their uninfected counterparts. This was significant for all serotypes except maternal GMC to serotype 1 and GMR for serotype 6B. In multivariate analysis, HIV was significantly associated with reduced odds of having protective pneumococcal IgG levels; 56-73% reduction for 3 maternal serotypes (4, 5, 23F) and 62-90% reduction for all cord samples except serotype 6B.
CONCLUSIONS: Maternal HIV infection is associated with lower levels of maternal pneumococcal antibodies and disproportionately lower cord antibodies, relative to maternal antibodies, suggesting that HIV infection compromises transplacental transfer. Reassessment of maternal and/or infant pneumococcal immunization strategies is needed in HIV-infected women and their infants.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibodies; Bangladesh; Cord; HIV; India; Maternal; Pneumococcus; Serotypes; Transplacental transfer

Mesh:

Substances:

Year:  2014        PMID: 24486350      PMCID: PMC3975143          DOI: 10.1016/j.vaccine.2014.01.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  42 in total

1.  Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-03-23

2.  Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh.

Authors:  W Abdullah Brooks; Robert F Breiman; Doli Goswami; Anowar Hossain; Khorshed Alam; Samir K Saha; Kamrun Nahar; Dilruba Nasrin; Noor Ahmed; Shams El Arifeen; Aliya Naheed; David A Sack; Stephen Luby
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

3.  Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants.

Authors:  Volia De Carvalho Almeida; Marisa Márcia Mussi-Pinhata; Cleonice Barbosa Sandoval De Souza; Christina Arslanian Kubo; Edson Zangiacomi Martinez; Magda Maria Carneiro-Sampaio; Geraldo Duarte
Journal:  Vaccine       Date:  2009-05-03       Impact factor: 3.641

4.  Effectiveness of maternal influenza immunization in mothers and infants.

Authors:  K Zaman; Eliza Roy; Shams E Arifeen; Mahbubur Rahman; Rubhana Raqib; Emily Wilson; Saad B Omer; Nigar S Shahid; Robert F Breiman; Robert E Breiman; Mark C Steinhoff
Journal:  N Engl J Med       Date:  2008-09-17       Impact factor: 91.245

Review 5.  The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease.

Authors:  Sandra J Bliss; Katherine L O'Brien; Edward N Janoff; Mark F Cotton; Philippa Musoke; Hoosen Coovadia; Orin S Levine
Journal:  Lancet Infect Dis       Date:  2007-10-31       Impact factor: 25.071

6.  Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.

Authors:  Katherine L O'Brien; Jennifer Moisi; Lawrence H Moulton; Dace Madore; Angelia Eick; Ray Reid; Robert Weatherholtz; Eugene Millar; Diana Hu; Jill Hackell; Robert Kohberger; George Siber; Mathuram Santosham
Journal:  J Infect Dis       Date:  2007-05-24       Impact factor: 5.226

7.  WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26-27 October 2006, Geneva.

Authors:  Thomas Cherian
Journal:  Vaccine       Date:  2007-07-16       Impact factor: 3.641

8.  Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

Authors:  Abubaker Bedri; Berhanu Gudetta; Abdulhamid Isehak; Solomon Kumbi; Sileshi Lulseged; Yohannes Mengistu; Arvind V Bhore; Ramesh Bhosale; Venkat Varadhrajan; Nikhil Gupte; Jayagowri Sastry; Nishi Suryavanshi; Srikanth Tripathy; Francis Mmiro; Michael Mubiru; Carolyne Onyango; Adrian Taylor; Philippa Musoke; Clemensia Nakabiito; Aida Abashawl; Rahel Adamu; Gretchen Antelman; Robert C Bollinger; Patricia Bright; Mohammad A Chaudhary; Jacqueline Coberly; Laura Guay; Mary Glenn Fowler; Amita Gupta; Elham Hassen; J Brooks Jackson; Lawrence H Moulton; Uma Nayak; Saad B Omer; Lidia Propper; Malathi Ram; Vivian Rexroad; Andrea J Ruff; Anita Shankar; Sheryl Zwerski
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

9.  Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.

Authors:  Shams E Arifeen; Samir K Saha; Sayedur Rahman; Kazi Mizanur Rahman; Syed Moshfiqur Rahman; Sanwarul Bari; Aliya Naheed; Ishtiaq Mannan; M Habibur R Seraji; Nawshad U Ahmed; M Shameem Hassan; Nazmul Huda; Ashraf Uddin Siddik; Iftekhar Quasem; Maksuda Islam; Kaniz Fatima; Hassan Al-Emran; W Abdullah Brooks; Abdullah H Baqui; Robert F Breiman; David Sack; Stephen P Luby
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

10.  Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.

Authors:  Samir K Saha; Aliya Naheed; Shams El Arifeen; Maksuda Islam; Hassan Al-Emran; Ruhul Amin; Kaniz Fatima; W Abdullah Brooks; Robert F Breiman; David A Sack; Stephen P Luby
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

View more
  16 in total

1.  Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.

Authors:  David R Martinez; Youyi Fong; Shuk Hang Li; Fang Yang; Madeleine F Jennewein; Joshua A Weiner; Erin A Harrell; Jesse F Mangold; Ria Goswami; George R Seage; Galit Alter; Margaret E Ackerman; Xinxia Peng; Genevieve G Fouda; Sallie R Permar
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

2.  Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants.

Authors:  James T Gaensbauer; Jeremy T Rakhola; Carolyne Onyango-Makumbi; Michael Mubiru; Jamie E Westcott; Nancy F Krebs; Edwin J Asturias; Mary Glenn Fowler; Elizabeth McFarland; Edward N Janoff
Journal:  Clin Vaccine Immunol       Date:  2014-10-08

Review 3.  Maternal immunisation to improve the health of HIV-exposed infants.

Authors:  Angela M Bengtson; Alan M Sanfilippo; Brenna L Hughes; David A Savitz
Journal:  Lancet Infect Dis       Date:  2018-12-07       Impact factor: 25.071

4.  Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.

Authors:  Jessica E Atwell; Bhagvanji Thumar; Leanne J Robinson; Roselyn Tobby; Phantica Yambo; Maria Ome-Kaius; Peter M Siba; Holger W Unger; Stephen J Rogerson; Christopher L King; Ruth A Karron
Journal:  J Infect Dis       Date:  2015-08-03       Impact factor: 5.226

5.  Rates of Hospitalization and Infection-Related Hospitalization Among Human Immunodeficiency Virus (HIV)-Exposed Uninfected Children Compared to HIV-Unexposed Uninfected Children in the United States, 2007-2016.

Authors:  Sarah M Labuda; Yanling Huo; Deborah Kacanek; Kunjal Patel; Krista Huybrechts; Jennifer Jao; Christiana Smith; Sonia Hernandez-Diaz; Gwendolyn Scott; Sandra Burchett; Fatima Kakkar; Ellen G Chadwick; Russell B Van Dyke
Journal:  Clin Infect Dis       Date:  2020-07-11       Impact factor: 9.079

6.  Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection.

Authors:  Kirsty Le Doare; Lauren Allen; Beate Kampmann; Paul Trafford Heath; Stephen Taylor; Anneke C Hesseling; Andrew Gorringe; Christine Elizabeth Jones
Journal:  Vaccine       Date:  2014-12-24       Impact factor: 3.641

Review 7.  Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns.

Authors:  Bahaa Abu-Raya; Kinga K Smolen; Fabienne Willems; Tobias R Kollmann; Arnaud Marchant
Journal:  Front Immunol       Date:  2016-08-31       Impact factor: 7.561

8.  Pneumococcal Acquisition Among Infants Exposed to HIV in Rural Malawi: A Longitudinal Household Study.

Authors:  Ellen Heinsbroek; Terence Tafatatha; Christina Chisambo; Amos Phiri; Oddie Mwiba; Bagrey Ngwira; Amelia C Crampin; Jonathan M Read; Neil French
Journal:  Am J Epidemiol       Date:  2015-12-01       Impact factor: 4.897

9.  Maternal Human Immunodeficiency Virus-Associated Hypergammaglobulinemia Reduces Transplacental Transfer of Immunoglobulin G to Plasmodium falciparum Antigens in Cameroonian Neonates.

Authors:  Anna Babakhanyan; Gabriel Loni Ekali; Arlene Dent; James Kazura; John Tamo Nguasong; Barriere Airy Yetgang Fodjo; Emile Keming Yuosembom; Livo Forgu Esemu; Diane Wallace Taylor; Rose Gana Fomban Leke
Journal:  Open Forum Infect Dis       Date:  2016-05-10       Impact factor: 3.835

10.  Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy.

Authors:  Aristine Cheng; Sui-Yuan Chang; Mao-Song Tsai; Yi-Ching Su; Wen-Chun Liu; Hsin-Yun Sun; Chien-Ching Hung
Journal:  J Int AIDS Soc       Date:  2016-01-29       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.